Early-stage ER+ BC: No recurrence or mortality with systemic or vaginal hormone therapy August 22, 2022Breast Cancer
ER+ HER2− early BC: Patients with PEPI 0-1/pCR can safely skip adjuvant chemotherapyAugust 22, 2022Breast Cancer
Oral paclitaxel+encequidar offers a possible alternative to IV paclitaxel in metastatic BC August 22, 2022Breast Cancer
ERBB2-positive BC: Adding atezolizumab to PATH shows acceptable pCR rate in phase 2August 22, 2022Breast Cancer
Bed boost after WBI reduces local recurrence of ductal carcinoma in situ in the breastAugust 22, 2022Breast Cancer
Pembrolizumab+chemotherapy improves OS in a subgroup of patients with advanced TNBCAugust 22, 2022Breast Cancer
Metformin use not linked with CRC incidence in T2D patients on evading time-related biasesAugust 21, 2022Gastrointestinal Cancer
How efficient is neoadjuvant chemotherapy in mismatch repair deficient colon cancer?August 21, 2022Gastrointestinal Cancer
Specific clinical features indicate more timely prediagnostic investigations or referral for CRCAugust 21, 2022Gastrointestinal Cancer
Increasing CRC incidence: Can chemopreventive agents come to the rescue?August 21, 2022Gastrointestinal Cancer
